Saipro Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 18-12-2024
- Paid Up Capital ₹ 3.00 M
as on 18-12-2024
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.54 Cr
as on 18-12-2024
- Satisfied Charges ₹ 7.76 M
as on 18-12-2024
- Revenue -8.82%
(FY 2023)
- Profit -14.25%
(FY 2023)
- Ebitda -9.93%
(FY 2023)
- Net Worth 37.94%
(FY 2023)
- Total Assets 2.63%
(FY 2023)
About Saipro Biotech
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹2.54 Cr. The company has closed loans amounting to ₹7.76 M, as per Ministry of Corporate Affairs (MCA) records.
Maruti Walekar and Chingubai Valekar serve as directors at the Company.
- CIN/LLPIN
U01110PN2010PTC137758
- Company No.
137758
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Nov 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Saipro Biotech Private Limited offer?
Saipro Biotech Private Limited offers a wide range of products and services, including Cooking Spices and Masala, Cooking Paste, Flavours & Aromatics, Starch Powder, Fresh, Dried & Preserved Fruits, Fruit Powder, Cereals & Food Grains, Food Grains, Ayurvedic Powder and Medicinal Herbs, Herbal Powder.
Who are the key members and board of directors at Saipro Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maruti Walekar  | Director | 15-Nov-2010 | Current |
| Chingubai Valekar | Director | 15-Nov-2010 | Current |
Financial Performance of Saipro Biotech.
Saipro Biotech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.82% decrease. The company also saw a substantial fall in profitability, with a 14.25% decrease in profit. The company's net worth Soared by an impressive increase of 37.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saipro Biotech?
Unlock access to Saipro Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 19 Jan 2021 | ₹3.72 M | Open |
Hdfc Bank Limited Creation Date: 09 Oct 2019 | ₹2.17 Cr | Open |
Others Creation Date: 29 Apr 2011 | ₹7.76 M | Satisfied |
How Many Employees Work at Saipro Biotech?
Saipro Biotech has a workforce of 20 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saipro Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saipro Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
